MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus
Animals
Infectious pancreatic necrosis virus
/ physiology
Alphavirus
/ immunology
Virus Replication
Signal Transduction
Adaptor Proteins, Signal Transducing
/ metabolism
Fish Diseases
/ immunology
Alphavirus Infections
/ immunology
Salmon
/ virology
Fish Proteins
/ genetics
Interferon Regulatory Factor-3
/ metabolism
Birnaviridae Infections
/ immunology
MAVS
Sensing
TALEN
disruption
infectious pancreatic necrosis virus
salmonid alphavirus
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
14
03
2024
accepted:
13
05
2024
medline:
21
6
2024
pubmed:
21
6
2024
entrez:
21
6
2024
Statut:
epublish
Résumé
The mitochondrial anti-viral signaling (MAVS) protein is an intermediary adaptor protein of retinoic acid-inducible gene-1 (RIG-I) like receptor (RLR) signaling, which activates the transcription factor interferon (IFN) regulatory factor 3 (IRF3) and NF-kB to produce type I IFNs. MAVS expression has been reported in different fish species, but few studies have shown its functional role in anti-viral responses to fish viruses. In this study, we used the transcription activator-like effector nuclease (TALEN) as a gene editing tool to disrupt the function of MAVS in Chinook salmon (
Identifiants
pubmed: 38903507
doi: 10.3389/fimmu.2024.1401086
pmc: PMC11187282
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Fish Proteins
0
Interferon Regulatory Factor-3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1401086Informations de copyright
Copyright © 2024 Xu, Gamil, Wang, Munang’andu and Evensen.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.